Organism name | Citrus reticulata |
---|---|
Genus | Citrus |
Family | Rutaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Citrus reticulata |
---|---|
Linked NCBI taxonomy ID | 85571 |
Linked level | species |
Family in NCBI taxonomy | Rutaceae |
---|---|
ID | 23513 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
Species | Activity |
---|---|
Citrus reticulata Blanco | Antibacterial |
Citrus reticulata Blanco | Anticancer |
Citrus reticulata Blanco | Antiemetic |
Citrus reticulata Blanco | Antimetastatic |
Citrus reticulata Blanco | Antiseptic |
Citrus reticulata Blanco | Antispasmodic |
Citrus reticulata Blanco | Antiviral |
Citrus reticulata Blanco | Aphrodisiac |
Citrus reticulata Blanco | Aromatic |
Citrus reticulata Blanco | Astringent |
Citrus reticulata Blanco | Candidicide |
Citrus reticulata Blanco | Decongestant |
Citrus reticulata Blanco | Digestive |
Citrus reticulata Blanco | Expectorant |
Citrus reticulata Blanco | Fungicide |
Citrus reticulata Blanco | Gastrogogue |
Citrus reticulata Blanco | Laxative |
Citrus reticulata Blanco | Mucolytic |
Citrus reticulata Blanco | Myorelaxant |
Citrus reticulata Blanco | Secretagogue |
Citrus reticulata Blanco | Sedative |
Citrus reticulata Blanco | Stimulant |
Citrus reticulata Blanco | Thermogenic |
Citrus reticulata Blanco | Tonic |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003928
![]() |
Sudachitin
/ Menthocubanone / Menthokubanone / 4',5,7-Trihydroxy-3',6,8-trimethoxyflavone / 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL479233
|
No. 3 | No. 15 |
![]() |
|||
C00004544
![]() |
3-O-Methylalnusin
/ Alnusin 3-methyl ether / 5,7-Dihydroxy-3,6-dimethoxyflavone / 5,7-Dihydroxy-3,6-dimethoxy-2-phenyl-4H-1-benzopyran-4-one |
No. 3 | No. 15 |
![]() |
||||
C00003845
![]() |
Eupatilin
/ 2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-4H-1-benzopyran-4-one |
CHEMBL312750
|
C045325
|
15 / 7 / 2 | No. 3 | No. 15 |
![]() |
|
C00003852
![]() |
Isoscutellarein 7,8-dimethyl ether
|
No. 3 | No. 15 |
![]() |
||||
C00003898
![]() |
5-Hydroxy-6,7,3',4'-tetramethoxyflavone
/ 6-Hydroxyluteolin 6,7,3',4'-tetramethyl ether / 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL226508
|
C045324
|
No. 8 | No. 15 |
![]() |
||
C00003871
![]() |
5,7,3',4'-Tetramethoxyflavone
/ Luteolin 5,7,3',4'-tetramethyl ether |
CHEMBL327340
|
C103111
|
1 / 0 | No. 8 | No. 15 |
![]() |
|
C00003897
![]() |
6-Hydroxyluteolin 5,6,3',4'-tetramethyl ether
|
No. 8 | No. 15 |
![]() |
||||
C00003935
![]() |
3'-Hydroxy-5,6,7,8,4'-pentamethoxyflavone
|
CHEMBL225704
|
No. 8 | No. 15 |
![]() |
|||
C00003912
![]() |
Isosinensetin
/ 6-Demethoxynobiletin / 5,7,8,3',4'-Pentamethoxyflavone / 2-(3,4-Dimethoxyphenyl)-5,7,8-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL451707
|
No. 8 | No. 15 |
![]() |
|||
C00013315
![]() |
4'-Hydroxy-5,6,7,8-tetramethoxyflavone
/ 2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one |
CHEMBL479077
|
No. 8 | No. 15 |
![]() |
|||
C00004804
![]() |
3,3',4',5,6,7,8-Heptamethoxyflavone
/ 3,5,6,7,8,3',4'-Heptamethoxyflavone / 2-(3,4-Dimethoxyphenyl)-3,5,6,7,8-pentamethoxy-4H-1-benzopyran-4-one |
CHEMBL77993
|
C059294
|
17 / 10 / 2 | No. 8 | No. 15 |
![]() |
|
C00003936
![]() |
Demethylnobiletin
/ 5-Hydroxy-6,7,8,3',4'-pentamethoxyflavone / 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7,8-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL75978
|
21 / 22 / 16 | No. 8 | No. 15 |
![]() |
||
C00005079
![]() |
4'-Hydroxy-3,6-dimethoxy-6'',6''-dimethylpyrano[2,3:7,8]flavone
|
No. 24 | No. 15 |
![]() |
||||
C00000931
![]() |
Zeaxanthin
/ all-trans-Zeaxanthin |
CHEMBL1357855
CHEMBL2359248 |
C005881
|
4 / 2 / 3 | 1 / 0 | No. 26 | No. 59 |
![]() |
C00003854
![]() |
5-Hydroxy-7,8,4'-trimethoxyflavone
/ 5-Hydroxy-4',7,8-trimethoxyflavone / Isoscutellarein 7,8,4'-trimethyl ether / 5-Hydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
No. 35 | No. 15 |
![]() |
||||
C00003821
![]() |
5,7,4'-Trimethoxyflavone
/ Apigenin 5,7,4'-trimethyl ether |
CHEMBL1087720
|
C103112
|
1 / 1 / 0 | 1 / 0 | No. 35 | No. 15 |
![]() |
C00000001
![]() |
GA1
/ Gibberellin A1 |
C422660
|
No. 40 | No. 41 |
![]() |
|||
C00000008
![]() |
GA8
/ Gibberellin A8 |
No. 40 | No. 41 |
![]() |
||||
C00000044
![]() |
GA44
/ Gibberellin A44 |
No. 40 | No. 41 |
![]() |
||||
C00000029
![]() |
GA29
/ Gibberellin A29 |
No. 40 | No. 41 |
![]() |
||||
C00000004
![]() |
GA4
/ Gibberellin A4 |
No. 40 | No. 41 |
![]() |
||||
C00000020
![]() |
GA20
/ Gibberellin A20 |
No. 40 | No. 41 |
![]() |
||||
C00003785
![]() |
Rubixanthin
|
No. 131 | No. 59 |
![]() |
||||
C00000019
![]() |
GA19
/ Gibberellin A19 |
C120175
|
No. 187 | No. 41 |
![]() |
|||
C00000017
![]() |
GA17
/ Gibberellin A17 |
No. 187 | No. 41 |
![]() |
||||
C00000053
![]() |
GA53
/ Gibberellin A53 |
No. 187 | No. 41 |
![]() |
||||
C00003131
![]() |
beta-Farnesene
/ (E)-beta-Farnesene / beta-trans-Farnesene |
C062671
|
No. 404 | No. 38 |
![]() |
|||
C00048367
![]() |
Curcumene
|
CHEMBL469717
|
C086829
|
No. 456 | No. 38 |
![]() |
||
C00000816
![]() |
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
![]() |
||
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00003110
![]() |
Caryophyllene
/ (E)-Caryophyllene / beta-Caryophyllene / (-)-(E)-Caryophyllene / (E)-beta-Caryophyllene |
CHEMBL445740
CHEMBL448700 |
2 / 3 / 7 | No. 478 | No. 38 |
![]() |
||
C00001265
![]() |
Pentadecane
|
CHEMBL1234557
|
C033245
|
2 / 8 / 37 | No. 599 |
![]() |
||
C00030472
![]() |
Heptadecane
|
C016486
|
No. 599 |
![]() |
||||
C00048301
![]() |
8-Heptadecene
|
No. 599 |
![]() |
|||||
C00007242
![]() |
beta-Bisabolene
/ l-beta-Bisabolene / (-)-beta-Bisabolene |
CHEMBL444389
CHEMBL1077088 CHEMBL2001434 |
No. 701 | No. 38 |
![]() |
|||
C00003166
![]() |
Nerolidol
|
CHEMBL25424
CHEMBL508801 CHEMBL561014 CHEMBL1923157 |
3 / 3 / 1 | No. 726 | No. 38 |
![]() |
||
C00020074
![]() |
Calamenene
/ (-)-cis-Calamenene |
No. 824 |
![]() |
|||||
C00000823
![]() |
Limonene
|
CHEMBL15799
CHEMBL449062 |
C008281
|
7 / 21 / 48 | 6 / 6 | No. 848 | No. 35 |
![]() |
C00003050
![]() |
Perilla aldehyde
/ (R)-(+)-Perillaldehyde |
CHEMBL442913
CHEMBL469537 |
C033342
|
2 / 1 / 0 | 9 / 0 | No. 848 | No. 35 |
![]() |
C00007535
![]() |
Phenylacetaldehyde
/ Benzeneacetaldehyde / Phenylacetic aldehyde |
C013192
|
3 / 0 | No. 885 |
![]() |
|||
C00048326
![]() |
Benzene acetonitrile
|
No. 885 |
![]() |
|||||
C00002663
![]() |
2-Phenylethanol
/ Phenethyl alcohol / Phenylethyl alcohol / beta-Phenethyl alcohol |
CHEMBL448500
|
D010626
|
2 / 1 / 1 | No. 885 |
![]() |
||
C00003047
![]() |
Linalool
/ (R)-linalool / (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol |
CHEMBL25306
CHEMBL235672 |
C018584
|
6 / 8 / 2 | 35 / 4 | No. 958 | No. 34 |
![]() |
C00000155
![]() |
Thymol
|
CHEMBL29411
|
D013943
|
9 / 17 / 14 | 12 / 0 | No. 969 | No. 35 |
![]() |
C00000184
![]() |
alpha-Thujene
|
No. 1343 | No. 35 |
![]() |
||||
C00031258
![]() |
Sabinene
/ 4(10)-Thujene |
CHEMBL452687
|
C035127
|
No. 1343 | No. 35 |
![]() |
||
C00007453
![]() |
Cyclohexane
/ beta-Elemene |
CHEMBL448502
CHEMBL479707 |
No. 1400 |
![]() |
||||
C00010883
![]() |
Carveol
/ p-Mentha-1,8-dien-6-ol |
CHEMBL1385229
CHEMBL1907992 CHEMBL1908058 |
C075856
|
6 / 15 / 40 | 1 / 0 | No. 1555 | No. 35 |
![]() |
C00003035
![]() |
Geranial
/ (E)-alpha-Citral |
CHEMBL1080997
|
6 / 7 / 9 | No. 1575 | No. 34 |
![]() |
||
C00000855
![]() |
Nerol
/ cis-Geraniol |
CHEMBL25719
CHEMBL452683 |
96 / 41 / 41 | No. 1575 | No. 34 |
![]() |
||
C00048486
![]() |
Neo-allo-ocimene
|
No. 1698 | No. 34 |
![]() |
||||
C00048310
![]() |
Allo-Ocimene
|
C015659
|
No. 1698 | No. 34 |
![]() |
|||
C00030767
![]() |
Methyl salicylate
|
CHEMBL108545
|
C033069
|
92 / 52 / 46 | 29 / 3 | No. 2169 |
![]() |
|
C00003040
![]() |
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
![]() |
||
C00000853
![]() |
Myrcene
|
CHEMBL455491
|
C008574
|
3 / 3 / 3 | No. 2285 | No. 34 |
![]() |
|
C00048315
![]() |
alpha-Myrcene
|
No. 2285 | No. 34 |
![]() |
||||
C00003060
![]() |
alpha-Terpinene
|
No. 2468 | No. 35 |
![]() |
||||
C00029353
![]() |
(Z)-Jasmone
/ cis-Jasmone |
C086299
|
No. 3251 |
![]() |
||||
C00001418
![]() |
Indole
|
CHEMBL15844
|
C030374
|
13 / 5 / 6 | 6 / 0 | No. 3673 |
![]() |
|
C00000861
![]() |
Terpinolene
|
CHEMBL454697
|
C027009
|
1 / 0 | No. 3725 |
![]() |
||
C00034600
![]() |
Methyl anthranilate
|
CHEMBL1493986
|
C038892
|
3 / 3 / 3 | No. 4170 |
![]() |
||
C00048248
![]() |
(Z)-Ocimene
/ cis-Ocimene |
No. 4949 |
![]() |
|||||
C00048263
![]() |
2,6-Dimethyl-1,3,5,7-octatetraene
|
No. 4953 |
![]() |
|||||
C00034775
![]() |
6-Methyl-5-hepten-2-one
|
CHEMBL46340
|
C029750
|
No. 5297 |
![]() |
|||
C00048304
![]() |
Acetone
|
CHEMBL14253
|
D000096
|
1 / 11 / 10 | 10 / 8 | No. 5308 |
![]() |
|
C00000136
![]() |
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
![]() |
||
C00034989
![]() |
(E)-Ocimene
/ trans-Ocimene |
No. 6181 |
![]() |
|||||
C00034452
![]() |
Benzaldehyde
|
CHEMBL15972
|
C032175
|
8 / 7 / 3 | 3 / 1 | No. 6311 |
![]() |
|
C00048350
![]() |
Carvyl acetate
|
CHEMBL1351619
|
4 / 3 / 2 | No. 6846 |
![]() |
|||
C00048498
![]() |
n-Phenylformamide
|
CHEMBL1232659
|
C045976
|
6 / 2 / 0 | No. 8296 |
![]() |
||
C00019560
![]() |
Ethanol
|
CHEMBL545
|
D000431
|
92 / 39 / 33 | 199 / 193 | No. 8862 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00000805 C00000853 C00010883 C00019560 C00030767 C00048350 | 3 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00000155 C00000823 C00003936 C00030767 C00048304 | 11 / 10 |
P03372 | Estrogen receptor | NR3A1 | C00000136 C00000855 C00001265 C00019560 C00030767 C00034452 | 1 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 C00000805 C00000855 C00003936 C00019560 C00030767 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003035 C00003936 C00019560 C00034452 C00034600 C00048498 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 C00000155 C00000823 C00000855 C00019560 C00030767 | 0 / 3 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00000855 C00003936 C00019560 C00030767 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000136 C00000855 C00001418 C00019560 C00030767 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 C00000855 C00019560 C00030767 C00034452 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000136 C00000853 C00000855 C00019560 C00030767 | 0 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P29466 | Caspase-1 | C14 | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000823 C00000855 C00034452 C00048498 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000136 C00000855 C00019560 C00030767 | 2 / 2 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000823 C00003035 C00003047 C00003166 | 3 / 1 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000136 C00000855 C00019560 C00030767 | 2 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 C00000855 C00019560 C00030767 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00000855 C00019560 C00030767 | 0 / 1 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 C00000855 C00019560 C00030767 | 1 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000823 C00034600 C00048350 C00048498 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00000855 C00019560 C00030767 | 1 / 8 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 C00000855 C00019560 C00030767 | 2 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 C00000855 C00019560 C00030767 | 2 / 1 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 C00000855 C00019560 C00030767 | 2 / 2 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 C00000855 C00019560 C00030767 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00000855 C00019560 C00030767 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000855 C00003047 C00003166 C00048350 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000136 C00000931 C00002663 C00048498 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000136 C00000855 C00019560 C00030767 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000136 C00000855 C00019560 C00030767 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000136 C00000855 C00019560 C00030767 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 C00000855 C00019560 C00030767 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 C00000855 C00019560 C00030767 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00000855 C00019560 C00030767 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 C00000855 C00019560 C00030767 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 C00000855 C00019560 C00030767 | 1 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00000855 C00019560 C00030767 | 0 / 0 |
Q9BVA1 | Tubulin beta-2B chain | Structural | C00003845 C00003936 C00004804 | 1 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | C00003845 C00003936 C00004804 | 0 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | C00003845 C00003936 C00004804 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000823 C00001265 C00010883 | 7 / 37 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00019560 C00048350 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000155 C00000855 C00003047 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000155 C00003047 C00010883 | 3 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | C00003845 C00003936 C00004804 | 0 / 0 |
Q13748 | Tubulin alpha-3C/D chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | C00003845 C00003936 C00004804 | 2 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 C00003047 C00048498 | 0 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
P68371 | Tubulin beta-4B chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | C00003845 C00003936 C00004804 | 1 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000855 C00000931 C00030767 | 2 / 3 |
Q9H4B7 | Tubulin beta-1 chain | Structural | C00003845 C00003936 C00004804 | 1 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000155 C00003047 C00010883 | 5 / 1 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
P04350 | Tubulin beta-4A chain | Structural | C00003845 C00003936 C00004804 | 2 / 0 |
P07437 | Tubulin beta chain | Structural | C00003845 C00003936 C00004804 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00034452 C00048498 | 2 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 C00003936 | 4 / 3 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000155 C00010883 | 0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00003035 C00003050 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000136 C00003035 | 3 / 4 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000931 C00003166 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00003821 C00004804 | 1 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000855 C00003110 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00000855 C00003110 | 2 / 5 |
Q96RI1 | Bile acid receptor | NR1H4 | C00000853 C00000855 | 0 / 0 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000155 C00003050 | 1 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
P23141 | Liver carboxylesterase 1 | Enzyme | C00001418 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001418 | 1 / 1 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000931 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002663 | 1 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003936 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000823 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003035 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003035 | 1 / 4 |
P05107 | Integrin beta-2 | Membrane receptor | C00001418 | 1 / 1 |
P05362 | Intercellular adhesion molecule 1 | Adhesion | C00001418 | 1 / 2 |
P20701 | Integrin alpha-L | Membrane receptor | C00001418 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00001418 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00001418 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000155 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001418 | 0 / 0 |
P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00034452 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000155 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00034452 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001418 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00010883 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00001418 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001418 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00034452 | 4 / 2 |
P55263 | Adenosine kinase | Enzyme | C00001418 | 1 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004804 | 2 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00034600 | 3 / 3 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00007535
C00019560
C00030767
C00048304
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000823
C00019560
C00030767
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00003050
C00007535
C00019560
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00003047
C00019560
C00030767
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000861
C00003047
C00019560
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000155
C00000823
C00019560
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003047
C00019560
C00030767
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00003047
C00007535
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000823
C00003047
|
4852 | NPY, PYY4 | neuropeptide Y |
C00000823
C00003047
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000155
C00019560
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000155
C00019560
|
3678 | ITGA5, CD49e, FNRA, VLA5A | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
C00019560
C00048304
|
2263 | FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 | fibroblast growth factor receptor 2 (EC:2.7.10.1) |
C00019560
C00048304
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00019560
C00048304
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000823
C00003047
|
847 | CAT | catalase (EC:1.11.1.6) |
C00019560
C00048304
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00003050
C00010883
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00003050
C00019560
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000155
C00030767
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000155
C00030767
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003047
C00019560
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003047
C00019560
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000155
C00030767
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000155
C00019560
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003047
C00019560
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00019560
C00030767
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00019560
C00030767
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00019560
C00034452
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00003047
C00003050
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00019560
C00048304
|
5884 | RAD17, CCYC, HRAD17, R24L, RAD17SP, RAD24 | RAD17 homolog (S. pombe) |
C00019560
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003047
|
8850 | KAT2B, CAF, P, P/CAF, PCAF | K(lysine) acetyltransferase 2B (EC:2.3.1.48) |
C00003047
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00003047
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00003047
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00003047
|
100124292 |
C00003047
|
||
3316 | HSPB2, HSP27, Hs.78846, LOH11CR1K, MKBP | heat shock 27kDa protein 2 |
C00003047
|
7471 | WNT1, BMND16, INT1, OI15 | wingless-type MMTV integration site family, member 1 |
C00003047
|
26118 | WSB1, SWIP1, WSB-1 | WD repeat and SOCS box containing 1 |
C00003047
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001418
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00001418
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00001418
|
4159 | MC3R, BMIQ9, MC3, MC3-R, OB20, OQTL | melanocortin 3 receptor |
C00001418
|
4160 | MC4R | melanocortin 4 receptor |
C00001418
|
4161 | MC5R, MC2 | melanocortin 5 receptor |
C00001418
|
3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00003047
|
218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00034452
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00034452
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00030767
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00030767
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00030767
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00030767
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00030767
|
2010 | EMD, EDMD, LEMD5, STA | emerin |
C00030767
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00003047
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00030767
|
3297 | HSF1, HSTF1 | heat shock transcription factor 1 |
C00003047
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00030767
|
9514 | GAL3ST1, CST | galactose-3-O-sulfotransferase 1 (EC:2.8.2.11) |
C00030767
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00030767
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00030767
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00030767
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00030767
|
4883 | NPR3, ANP-C, ANPR-C, ANPRC, C5orf23, GUCY2B, NPR-C, NPRC | natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
C00030767
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00030767
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00030767
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00030767
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00030767
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00030767
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003047
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00030767
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003047
|
1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00003047
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00003050
|
9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 |
C00003050
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00003050
|
1447 | CSN2, CASB | casein beta |
C00003047
|
5906 | RAP1A, KREV-1, KREV1, RAP1, SMGP21 | RAP1A, member of RAS oncogene family |
C00003050
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00003050
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003047
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00003871
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00003821
|
1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003047
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003047
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00048304
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003047
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003047
|
3596 | IL13, IL-13, P600 | interleukin 13 |
C00048304
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00048304
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00048304
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003047
|
23536 | ADAT1, HADAT1 | adenosine deaminase, tRNA-specific 1 (EC:3.5.4.34) |
C00019560
|
124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00019560
|
125 | ADH1B, ADH2 | alcohol dehydrogenase 1B (class I), beta polypeptide (EC:1.1.1.1) |
C00019560
|
126 | ADH1C, ADH3 | alcohol dehydrogenase 1C (class I), gamma polypeptide (EC:1.1.1.1) |
C00019560
|
127 | ADH4, ADH-2 | alcohol dehydrogenase 4 (class II), pi polypeptide (EC:1.1.1.1) |
C00019560
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00019560
|
131 | ADH7, ADH4 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (EC:1.1.1.1) |
C00019560
|
22977 | AKR7A3, AFAR2 | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
C00019560
|
273 | AMPH, AMPH1 | amphiphysin |
C00019560
|
162 | AP1B1, ADTB1, AP105A, BAM22, CLAPB2 | adaptor-related protein complex 1, beta 1 subunit |
C00019560
|
79065 | ATG9A, APG9L1, MGD3208, mATG9 | autophagy related 9A |
C00019560
|
506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00019560
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00003047
|
8678 | BECN1, ATG6, VPS30, beclin1 | beclin 1, autophagy related |
C00019560
|
274 | BIN1, AMPH2, AMPHL, SH3P9 | bridging integrator 1 |
C00019560
|
708 | C1QBP, GC1QBP, HABP1, SF2p32, gC1Q-R, gC1qR, p32 | complement component 1, q subcomponent binding protein |
C00019560
|
832 | CAPZB, CAPB, CAPPB, CAPZ | capping protein (actin filament) muscle Z-line, beta |
C00019560
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000823
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000931
|
857 | CAV1, BSCL3, CGL3, MSTP085, PPH3, VIP21, CAV | caveolin 1, caveolae protein, 22kDa |
C00019560
|
83446 | CCDC70 | coiled-coil domain containing 70 |
C00019560
|
54535 | CCHCR1, C6orf18, HCR, SBP | coiled-coil alpha-helical rod protein 1 |
C00019560
|
894 | CCND2, KIAK0002 | cyclin D2 |
C00019560
|
994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00019560
|
55664 | CDC37L1, CDC37B, HARC | cell division cycle 37-like 1 |
C00019560
|
1003 | CDH5, 7B4, CD144 | cadherin 5, type 2 (vascular endothelium) |
C00019560
|
23552 | CDK20, CCRK, CDCH, P42, PNQALRE | cyclin-dependent kinase 20 (EC:2.7.11.22) |
C00019560
|
1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00019560
|
55165 | CEP55, C10orf3, CT111, URCC6 | centrosomal protein 55kDa |
C00019560
|
1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00019560
|
1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00019560
|
1140 | CHRNB1, ACHRB, CHRNB, CMS1D, CMS2A, SCCMS | cholinergic receptor, nicotinic, beta 1 (muscle) |
C00019560
|
1191 | CLU, APO-J, APOJ, CLI, CLU1, CLU2, KUB1, NA1/NA2, SGP-2, SGP2, SP-40, TRPM-2, TRPM2 | clusterin |
C00019560
|
1266 | CNN3 | calponin 3, acidic |
C00019560
|
1278 | COL1A2, OI4 | collagen, type I, alpha 2 |
C00019560
|
1417 | CRYBB3, CATCN2, CRYB3, CTRCT22 | crystallin, beta B3 |
C00019560
|
1442 | CSH1, CS-1, CSA, CSMT, PL, hCS-A | chorionic somatomammotropin hormone 1 (placental lactogen) |
C00019560
|
1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00019560
|
1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00019560
|
54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00019560
|
10591 | DNPH1, C6orf108, RCL, RP3-330M21.3, dJ330M21.3 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
C00019560
|
1837 | DTNA, D18S892E, DRP3, DTN, DTN-A, LVNC1 | dystrobrevin, alpha |
C00019560
|
338599 | DUPD1, DUSP27, FMDSP | dual specificity phosphatase and pro isomerase domain containing 1 (EC:3.1.3.16 3.1.3.48) |
C00019560
|
2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00019560
|
10961 | ERP29, C12orf8, ERp28, ERp31, PDI-DB, PDIA9 | endoplasmic reticulum protein 29 |
C00019560
|
2177 | FANCD2, FA-D2, FA4, FACD, FAD, FAD2, FANCD | Fanconi anemia, complementation group D2 |
C00019560
|
84261 | FBXW9, Fbw9 | F-box and WD repeat domain containing 9 |
C00019560
|
2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00019560
|
2526 | FUT4, CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX, SSEA-1 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) (EC:2.4.1.-) |
C00019560
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00019560
|
2670 | GFAP | glial fibrillary acidic protein |
C00019560
|
2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00019560
|
51031 | GLOD4, C17orf25, HC71 | glyoxalase domain containing 4 |
C00019560
|
2741 | GLRA1, HKPX1, STHE | glycine receptor, alpha 1 |
C00019560
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00019560
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00019560
|
2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00019560
|
57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00019560
|
1839 | HBEGF, DTR, DTS, DTSF, HEGFL | heparin-binding EGF-like growth factor |
C00019560
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00019560
|
3181 | HNRNPA2B1, HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2, RNPA2, SNRPB1 | heterogeneous nuclear ribonucleoprotein A2/B1 |
C00019560
|
3190 | HNRNPK, CSBP, HNRPK, TUNP | heterogeneous nuclear ribonucleoprotein K |
C00019560
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00019560
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00019560
|
27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00019560
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00019560
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00019560
|
3486 | IGFBP3, BP-53, IBP3 | insulin-like growth factor binding protein 3 |
C00019560
|
3589 | IL11, AGIF, IL-11 | interleukin 11 |
C00019560
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00019560
|
3708 | ITPR1, INSP3R1, IP3R, IP3R1, SCA15, SCA16, SCA29 | inositol 1,4,5-trisphosphate receptor, type 1 |
C00019560
|
83999 | KREMEN1, KREMEN, KRM1 | kringle containing transmembrane protein 1 |
C00019560
|
3875 | KRT18, CYK18, K18 | keratin 18 |
C00019560
|
3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00019560
|
3897 | L1CAM, CAML1, CD171, HSAS, HSAS1, MASA, MIC5, N-CAM-L1, N-CAML1, NCAM-L1, S10, SPG1 | L1 cell adhesion molecule |
C00019560
|
4017 | LOXL2, LOR2, WS9-14 | lysyl oxidase-like 2 (EC:1.4.3.-) |
C00019560
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00019560
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00019560
|
4144 | MAT2A, MATA2, MATII, SAMS2 | methionine adenosyltransferase II, alpha (EC:2.5.1.6) |
C00019560
|
4148 | MATN3, DIPOA, EDM5, HOA, OADIP, OS2 | matrilin 3 |
C00019560
|
406931 | MIR139, MIR139-3p, MIRN139 | microRNA 139 |
C00019560
|
406987 | MIR204, MIRN204, miRNA204 | microRNA 204 |
C00019560
|
100126336 | MIR208B, MIRN208B | microRNA 208b |
C00019560
|
407018 | MIR27A, MIR27, MIRN27A | microRNA 27a |
C00019560
|
442894 | MIR302B, MIRN302B | microRNA 302b |
C00019560
|
693120 | MIR33B, MIRN33B, hsa-mir-33b | microRNA 33b |
C00019560
|
407040 | MIR34A, MIRN34A, miRNA34A, mir-34 | microRNA 34a |
C00019560
|
442914 | MIR369, MIR369-3, MIRN369, MIRN369-3, hsa-mir-369 | microRNA 369 |
C00019560
|
442915 | MIR370, MIRN370, hsa-mir-370 | microRNA 370 |
C00019560
|
442918 | MIR373, MIRN373, hsa-mir-373, miRNA373 | microRNA 373 |
C00019560
|
494324 | MIR375, MIRN375, hsa-mir-375, miRNA375 | microRNA 375 |
C00019560
|
574451 | MIR432, MIRN432, hsa-mir-432 | microRNA 432 |
C00019560
|
619552 | MIR483, MIRN483, hsa-mir-483 | microRNA 483 |
C00019560
|
574450 | MIR493, MIRN493, hsa-mir-493 | microRNA 493 |
C00019560
|
574456 | MIR497, MIRN497, hsa-mir-497 | microRNA 497 |
C00019560
|
574472 | MIR518F, MIRN518F | microRNA 518f |
C00019560
|
574471 | MIR523, MIRN523, hsa-mir-523 | microRNA 523 |
C00019560
|
693191 | MIR606, MIRN606, hsa-mir-606 | microRNA 606 |
C00019560
|
724026 | MIR656, MIRN656, hsa-mir-656 | microRNA 656 |
C00019560
|
100126326 | MIR936, MIRN936, hsa-mir-936 | microRNA 936 |
C00019560
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00019560
|
4548 | MTR, HMAG, MS, cblG | 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) |
C00019560
|
4595 | MUTYH, CYP2C, MYH | mutY homolog (EC:3.2.2.-) |
C00019560
|
4638 | MYLK, AAT7, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK | myosin light chain kinase (EC:2.7.11.18) |
C00019560
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00019560
|
4688 | NCF2, NCF-2, NOXA2, P67-PHOX, P67PHOX | neutrophil cytosolic factor 2 |
C00019560
|
4791 | NFKB2, H2TF1, LYT-10, LYT10, NF-kB2, p105, p52 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
C00019560
|
4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00019560
|
8996 | NOL3, ARC, FCM, MYP, NOP, NOP30 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
C00019560
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00019560
|
4854 | NOTCH3, CADASIL, CASIL, IMF2 | notch 3 |
C00019560
|
27035 | NOX1, GP91-2, MOX1, NOH-1, NOH1 | NADPH oxidase 1 |
C00019560
|
4897 | NRCAM | neuronal cell adhesion molecule |
C00019560
|
8829 | NRP1, BDCA4, CD304, NP1, NRP, VEGF165R | neuropilin 1 |
C00019560
|
100506658 | OCLN, BLCPMG | occludin (EC:2.1.1.67) |
C00019560
|
4968 | OGG1, HMMH, HOGG1, MUTM, OGH1 | 8-oxoguanine DNA glycosylase (EC:4.2.99.18) |
C00019560
|
4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 |
C00019560
|
4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00019560
|
84876 | ORAI1, CRACM1, IMD9, ORAT1, TMEM142A | ORAI calcium release-activated calcium modulator 1 |
C00019560
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00019560
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00019560
|
5173 | PDYN, ADCA, PENKB, SCA23 | prodynorphin |
C00019560
|
5179 | PENK | proenkephalin |
C00019560
|
5204 | PFDN5, MM-1, MM1, PFD5 | prefoldin subunit 5 |
C00019560
|
25796 | PGLS, 6PGL | 6-phosphogluconolactonase (EC:3.1.1.31) |
C00019560
|
5245 | PHB, PHB1 | prohibitin |
C00019560
|
26227 | PHGDH, 3-PGDH, 3PGDH, PDG, PGAD, PGD, PGDH, SERA | phosphoglycerate dehydrogenase (EC:1.1.1.95) |
C00019560
|
5335 | PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1 | phospholipase C, gamma 1 (EC:3.1.4.11) |
C00019560
|
5352 | PLOD2, LH2, TLH | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (EC:1.14.11.4) |
C00019560
|
57048 | PLSCR3 | phospholipid scramblase 3 |
C00019560
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00019560
|
5395 | PMS2, HNPCC4, PMS2CL, PMSL2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) |
C00019560
|
5426 | POLE, CRCS12, FILS, POLE1 | polymerase (DNA directed), epsilon, catalytic subunit (EC:2.7.7.7) |
C00019560
|
5443 | POMC, ACTH, CLIP, LPH, MSH, NPP, POC | proopiomelanocortin |
C00019560
|
5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00019560
|
5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00019560
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00019560
|
100136658 |
C00019560
|
||
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00019560
|
8497 | PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
C00019560
|
5052 | PRDX1, MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB, PRX1, PRXI, TDPX2 | peroxiredoxin 1 (EC:1.11.1.15) |
C00019560
|
9588 | PRDX6, 1-Cys, AOP2, NSGPx, PRX, aiPLA2, p29 | peroxiredoxin 6 (EC:1.11.1.9 1.11.1.15) |
C00019560
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00019560
|
5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00019560
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00019560
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00019560
|
2185 | PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK | protein tyrosine kinase 2 beta (EC:2.7.10.2) |
C00019560
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00019560
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00003047
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00019560
|
6236 | RRAD, RAD, RAD1, REM3 | Ras-related associated with diabetes |
C00019560
|
6275 | S100A4, 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98 | S100 calcium binding protein A4 |
C00019560
|
6342 | SCP2, NLTP, NSL-TP, SCP-2, SCP-CHI, SCP-X, SCPX | sterol carrier protein 2 (EC:2.3.1.176) |
C00019560
|
23513 | SCRIB, CRIB1, SCRB1, SCRIB1, Vartul | scribbled planar cell polarity protein |
C00019560
|
6573 | SLC19A1, CHMD, FOLT, IFC1, REFC, RFC1 | solute carrier family 19 (folate transporter), member 1 |
C00019560
|
2030 | SLC29A1, ENT1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
C00019560
|
60682 | SMAP1, SMAP-1 | small ArfGAP 1 |
C00019560
|
6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00019560
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00019560
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00019560
|
6723 | SRM, PAPT, SPDSY, SPS1, SRML1 | spermidine synthase (EC:2.5.1.16) |
C00019560
|
56910 | STARD7, GTT1 | StAR-related lipid transfer (START) domain containing 7 |
C00019560
|
6786 | STIM1, D11S4896E, GOK, IMD10, TAM | stromal interaction molecule 1 |
C00019560
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00019560
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00019560
|
6783 | SULT1E1, EST, EST-1, ST1E1, STE | sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) |
C00019560
|
6822 | SULT2A1, DHEA-ST, DHEAS, HST, ST2, ST2A1, ST2A3, STD, hSTa | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14) |
C00019560
|
9095 | TBX19, TBS19, TPIT, dJ747L4.1 | T-box 19 |
C00019560
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00019560
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00019560
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00019560
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00019560
|
7083 | TK1, TK2 | thymidine kinase 1, soluble (EC:2.7.1.21) |
C00019560
|
7167 | TPI1, TIM, TPI, TPID | triosephosphate isomerase 1 (EC:5.3.1.1) |
C00019560
|
10107 | TRIM10, HERF1, RFB30, RNF9 | tripartite motif containing 10 |
C00019560
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00019560
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00019560
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00019560
|
7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00019560
|
25925 | ZNF521, EHZF, Evi3 | zinc finger protein 521 |
C00019560
|
9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00000155
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000155
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000155
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000155
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000155
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#614300 | Hypermethioninemia due to adenosine kinase deficiency |
P55263
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#116920 | Leukocyte adhesion deficiency, type i; lad |
P05107
|
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#608516 | Major depressive disorder; mdd |
P08172
|
#611162 | Malaria, susceptibility to |
P05362
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00099 | Leukocyte adhesion deficiency (LAD) |
P05107
(related)
|
H00083 | Allograft rejection |
P05362
(related)
|
H00080 | Systemic lupus erythematosus |
P05362
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D012640 | Seizures |
C00034452
C00048304 C00019560 |
D008569 | Memory Disorders |
C00000823
C00019560 |
D008107 | Liver Diseases |
C00000823
C00019560 |
D008114 | Liver Neoplasms, Experimental |
C00000823
C00019560 |
D056486 | Drug-Induced Liver Injury |
C00048304
C00019560 |
D013276 | Stomach Ulcer |
C00000823
C00019560 |
D009336 | Necrosis |
C00030767
C00019560 |
D009135 | Muscular Diseases |
C00030767
C00019560 |
D003877 | Dermatitis, Contact |
C00000805
C00000823 |
D012206 | Rhabdomyolysis |
C00019560
|
D007938 | Leukemia |
C00003047
|
D006937 | Hypercholesterolemia |
C00003047
|
D017453 | Dermatitis, Irritant |
C00003047
|
D009395 | Nephritis, Interstitial |
C00030767
|
D003389 | Cranial Nerve Diseases |
C00048304
|
D003556 | Cystitis |
C00048304
|
D007674 | Kidney Diseases |
C00000823
|
D007662 | Ketosis |
C00048304
|
D009374 | Neoplasms, Experimental |
C00048304
|
D012878 | Skin Neoplasms |
C00048304
|
D014555 | Urination Disorders |
C00048304
|
D000014 | Abnormalities, Drug-Induced |
C00019560
|
D000138 | Acidosis |
C00019560
|
D000140 | Acidosis, Lactic |
C00019560
|
D058186 | Acute Kidney Injury |
C00019560
|
D000402 | Airway Obstruction |
C00019560
|
D000435 | Alcoholic Intoxication |
C00019560
|
D020751 | Alcohol-Induced Disorders |
C00019560
|
D020268 | Alcohol-Induced Disorders, Nervous System |
C00019560
|
D000437 | Alcoholism |
C00019560
|
D019973 | Alcohol-Related Disorders |
C00019560
|
D020270 | Alcohol Withdrawal Seizures |
C00019560
|
D000647 | Amnesia |
C00019560
|
D020236 | Amnesia, Transient Global |
C00019560
|
D019969 | Amphetamine-Related Disorders |
C00019560
|
D000853 | Anophthalmos |
C00019560
|
D000855 | Anorexia |
C00019560
|
D001008 | Anxiety Disorders |
C00019560
|
D001028 | Aortopulmonary Septal Defect |
C00019560
|
D001247 | Asthenia |
C00019560
|
D001259 | Ataxia |
C00019560
|
D050197 | Atherosclerosis |
C00019560
|
D054537 | Atrioventricular Block |
C00019560
|
D001284 | Atrophy |
C00019560
|
D001342 | Autonomic Nervous System Diseases |
C00019560
|
D001714 | Bipolar Disorder |
C00019560
|
D001766 | Blindness |
C00019560
|
D001835 | Body Weight |
C00019560
|
D001919 | Bradycardia |
C00019560
|
D001927 | Brain Diseases |
C00019560
|
D001929 | Brain Edema |
C00019560
|
D001930 | Brain Injuries |
C00019560
|
D002545 | Brain Ischemia |
C00019560
|
D001986 | Bronchial Spasm |
C00019560
|
D002056 | Burns |
C00019560
|
D006528 | Carcinoma, Hepatocellular |
C00019560
|
D006332 | Cardiomegaly |
C00019560
|
D009202 | Cardiomyopathies |
C00019560
|
D002310 | Cardiomyopathy, Alcoholic |
C00019560
|
D002311 | Cardiomyopathy, Dilated |
C00019560
|
D002318 | Cardiovascular Diseases |
C00019560
|
D020215 | Carotid Artery, Internal, Dissection |
C00019560
|
D002493 | Central Nervous System Diseases |
C00019560
|
D002543 | Cerebral Hemorrhage |
C00019560
|
D002779 | Cholestasis |
C00019560
|
D002971 | Cleft Lip |
C00019560
|
D002972 | Cleft Palate |
C00019560
|
D019970 | Cocaine-Related Disorders |
C00019560
|
D003072 | Cognition Disorders |
C00019560
|
D003128 | COMA |
C00019560
|
D003221 | Confusion |
C00019560
|
C535464 | Conotruncal cardiac defects |
C00019560
|
D003244 | Consciousness Disorders |
C00019560
|
D019465 | Craniofacial Abnormalities |
C00019560
|
D003645 | Death, Sudden |
C00019560
|
D016757 | Death, Sudden, Cardiac |
C00019560
|
D003693 | Delirium |
C00019560
|
D003731 | Dental Caries |
C00019560
|
D003866 | Depressive Disorder |
C00019560
|
D003865 | Depressive Disorder, Major |
C00019560
|
D002658 | Developmental Disabilities |
C00019560
|
D004195 | Disease Models, Animal |
C00019560
|
D018450 | Disease Progression |
C00019560
|
D004244 | Dizziness |
C00019560
|
D056487 | Drug-Induced Liver Injury, Chronic |
C00019560
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00019560
|
D020820 | Dyskinesias |
C00019560
|
D004417 | Dyspnea |
C00019560
|
D004487 | Edema |
C00019560
|
D004830 | Epilepsy, Tonic-Clonic |
C00019560
|
D004938 | Esophageal Neoplasms |
C00019560
|
D020329 | Essential Tremor |
C00019560
|
D005234 | Fatty Liver |
C00019560
|
D005235 | Fatty Liver, Alcoholic |
C00019560
|
D063647 | Fetal Alcohol Spectrum Disorders |
C00019560
|
D005313 | Fetal Death |
C00019560
|
D005317 | Fetal Growth Retardation |
C00019560
|
D005355 | Fibrosis |
C00019560
|
D005483 | Flushing |
C00019560
|
D005756 | Gastritis |
C00019560
|
D005767 | Gastrointestinal Diseases |
C00019560
|
D006130 | Growth Disorders |
C00019560
|
D006212 | Hallucinations |
C00019560
|
D006323 | Heart Arrest |
C00019560
|
D006330 | Heart Defects, Congenital |
C00019560
|
D006331 | Heart Diseases |
C00019560
|
D006344 | Heart Septal Defects, Atrial |
C00019560
|
D006345 | Heart Septal Defects, Ventricular |
C00019560
|
D006470 | Hemorrhage |
C00019560
|
D020141 | Hemostatic Disorders |
C00019560
|
D006505 | Hepatitis |
C00019560
|
D006519 | Hepatitis, Alcoholic |
C00019560
|
D006529 | Hepatomegaly |
C00019560
|
D006869 | Hydronephrosis |
C00019560
|
D006930 | Hyperalgesia |
C00019560
|
D006940 | Hyperemia |
C00019560
|
D006945 | Hyperhidrosis |
C00019560
|
D006948 | Hyperkinesis |
C00019560
|
D006965 | Hyperplasia |
C00019560
|
D006973 | Hypertension |
C00019560
|
D015228 | Hypertriglyceridemia |
C00019560
|
D017379 | Hypertrophy, Left Ventricular |
C00019560
|
D007022 | Hypotension |
C00019560
|
D007035 | Hypothermia |
C00019560
|
D007154 | Immune System Diseases |
C00019560
|
D007249 | Inflammation |
C00019560
|
D008607 | Intellectual Disability |
C00019560
|
D020300 | Intracranial Hemorrhages |
C00019560
|
D007511 | Ischemia |
C00019560
|
D007565 | Jaundice |
C00019560
|
D007569 | Jaw Abnormalities |
C00019560
|
D007683 | Kidney Tubular Necrosis, Acute |
C00019560
|
D007859 | Learning Disorders |
C00019560
|
D017880 | Limb Deformities, Congenital |
C00019560
|
D008103 | Liver Cirrhosis |
C00019560
|
D008104 | Liver Cirrhosis, Alcoholic |
C00019560
|
D008106 | Liver Cirrhosis, Experimental |
C00019560
|
D008108 | Liver Diseases, Alcoholic |
C00019560
|
D017114 | Liver Failure, Acute |
C00019560
|
D008133 | Long QT Syndrome |
C00019560
|
D008175 | Lung Neoplasms |
C00019560
|
D008831 | Microcephaly |
C00019560
|
D048629 | Micronuclei, Chromosome-Defective |
C00019560
|
D008850 | Microphthalmos |
C00019560
|
D009059 | Mouth Diseases |
C00019560
|
D009069 | Movement Disorders |
C00019560
|
D009203 | Myocardial Infarction |
C00019560
|
D017202 | Myocardial Ischemia |
C00019560
|
D009325 | Nausea |
C00019560
|
D009361 | Neoplasm Invasiveness |
C00019560
|
D009362 | Neoplasm Metastasis |
C00019560
|
D009422 | Nervous System Diseases |
C00019560
|
D051474 | Neuralgia, Postherpetic |
C00019560
|
D009436 | Neural Tube Defects |
C00019560
|
D019954 | Neurobehavioral Manifestations |
C00019560
|
D020258 | Neurotoxicity Syndromes |
C00019560
|
D009901 | Optic Nerve Diseases |
C00019560
|
D010146 | Pain |
C00019560
|
D010190 | Pancreatic Neoplasms |
C00019560
|
D010195 | Pancreatitis |
C00019560
|
D019512 | Pancreatitis, Alcoholic |
C00019560
|
D010243 | Paralysis |
C00019560
|
D010523 | Peripheral Nervous System Diseases |
C00019560
|
D010538 | Peritonitis |
C00019560
|
D010698 | Phobic Disorders |
C00019560
|
D011041 | Poisoning |
C00019560
|
D011115 | Polyneuropathies |
C00019560
|
D017119 | Porphyria Cutanea Tarda |
C00019560
|
D011297 | Prenatal Exposure Delayed Effects |
C00019560
|
D049188 | Prenatal Injuries |
C00019560
|
D015175 | Prolactinoma |
C00019560
|
D011507 | Proteinuria |
C00019560
|
D011596 | Psychomotor Disorders |
C00019560
|
D011605 | Psychoses, Substance-Induced |
C00019560
|
D011654 | Pulmonary Edema |
C00019560
|
D015427 | Reperfusion Injury |
C00019560
|
D012141 | Respiratory Tract Infections |
C00019560
|
D012164 | Retinal Diseases |
C00019560
|
D009369 | Neoplasms |
C00003047
|
D018805 | Sepsis |
C00019560
|
D020018 | Sexual Dysfunctions, Psychological |
C00019560
|
D013272 | Stomach Diseases |
C00019560
|
D013274 | Stomach Neoplasms |
C00019560
|
D020521 | Stroke |
C00019560
|
D053608 | Stupor |
C00019560
|
D013345 | Subarachnoid Hemorrhage |
C00019560
|
D019966 | Substance-Related Disorders |
C00019560
|
D013375 | Substance Withdrawal Syndrome |
C00019560
|
D013610 | Tachycardia |
C00019560
|
D017180 | Tachycardia, Ventricular |
C00019560
|
D013683 | Telangiectasia, Hereditary Hemorrhagic |
C00019560
|
D013771 | Tetralogy of Fallot |
C00019560
|
D018677 | Tooth Injuries |
C00019560
|
D016388 | Tooth Loss |
C00019560
|
D016171 | Torsades de Pointes |
C00019560
|
D014202 | Tremor |
C00019560
|
D014474 | Unconsciousness |
C00019560
|
D016055 | Urinary Retention |
C00019560
|
D054079 | Vascular Malformations |
C00019560
|
D018487 | Ventricular Dysfunction, Left |
C00019560
|
D014693 | Ventricular Fibrillation |
C00019560
|
D018879 | Ventricular Premature Complexes |
C00019560
|
D014811 | Vitamin E Deficiency |
C00019560
|
D014839 | Vomiting |
C00019560
|
D015430 | Weight Gain |
C00019560
|
D015431 | Weight Loss |
C00019560
|